Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Positive Feedback Loop between Inactive VHL-Triggered Histone Lactylation and PDGFRβ Signaling Drives Clear Cell Renal Cell Carcinoma Progression. | Int J Biol Sci | 2022 | 35637958 | PubTator, text mining | PubMed |
| Altered Lipid Profile in COVID-19 Patients and Metabolic Reprogramming. | Front Microbiol | 2022 | 35633693 | PubTator, text mining | PubMed |
| Targeting Energy Metabolism in Cancer Treatment. | Int J Mol Sci | 2022 | 35628385 | PubTator, text mining | PubMed |
| Sperm Phosphoproteome: Unraveling Male Infertility. | Biology (Basel) | 2022 | 35625387 | PubTator, text mining | PubMed |
| Maternal autoantibody profiles as biomarkers for ASD and ASD with co-occurring intellectual disability. | Mol Psychiatry | 2022 | 35618885 | PubTator, text mining | PubMed |
| Identification of Differential Genes of DNA Methylation Associated With Alzheimer's Disease Based on Integrated Bioinformatics and Its Diagnostic Significance. | Front Aging Neurosci | 2022 | 35615586 | PubTator, text mining | PubMed |
| Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma. | Clin Proteomics | 2022 | 35610567 | PubTator, text mining | PubMed |
| USP40 deubiquitinates HINT1 and stabilizes p53 in podocyte damage. | Biochem Biophys Res Commun | 2022 | 35605301 | PubTator, text mining | PubMed |
| Regulation of Transactivation at C-TAD Domain of HIF-1α by Factor-Inhibiting HIF-1α (FIH-1): A Potential Target for Therapeutic Intervention in Cancer. | Oxid Med Cell Longev | 2022 | 35592530 | PubTator, text mining | PubMed |
| The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients. | Inflammation | 2022 | 35588340 | PubTator, text mining | PubMed |
| In-depth proteomics characterization of ∆Np73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer. | Mol Oncol | 2022 | 35586989 | PubTator, text mining | PubMed |
| TRPC5OS induces tumorigenesis by increasing ENO1-mediated glucose uptake in breast cancer. | Transl Oncol | 2022 | 35584604 | PubTator, text mining | PubMed |
| Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer. | Cancer Drug Resist | 2022 | 35582540 | PubTator, text mining | PubMed |
| Type 1 Insulin-Like Growth Factor Receptor Nuclear Localization in High-Grade Glioma Cells Enhances Motility, Metabolism, and In Vivo Tumorigenesis. | Front Endocrinol (Lausanne) | 2022 | 35574033 | PubTator, text mining | PubMed |
| Targeting Selective Autophagy as a Therapeutic Strategy for Viral Infectious Diseases. | Front Microbiol | 2022 | 35572624 | PubTator, text mining | PubMed |
| Lactate Is Answerable for Brain Function and Treating Brain Diseases: Energy Substrates and Signal Molecule. | Front Nutr | 2022 | 35571940 | PubTator, text mining | PubMed |
| KLF14 targets ITGB1 to inhibit the progression of cervical cancer via the PI3K/AKT signalling pathway. | Discov Oncol | 2022 | 35570248 | PubTator, text mining | PubMed |
| Genetic and Drug Inhibition of LDH-A: Effects on Murine Gliomas. | Cancers (Basel) | 2022 | 35565435 | PubTator, text mining | PubMed |
| LDH-A-Modulation and the Variability of LDH Isoenzyme Profiles in Murine Gliomas: A Link with Metabolic and Growth Responses. | Cancers (Basel) | 2022 | 35565432 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=42